Insider Transactions in Q3 2017 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,348
-2.31%
|
$126,792
$54.6 P/Share
|
|
Sep 18
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,703
-10.99%
|
$523,962
$54.48 P/Share
|
|
Sep 18
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
4,682
-7.73%
|
$252,828
$54.55 P/Share
|
|
Sep 15
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
4,245
-6.55%
|
$229,230
$54.85 P/Share
|
|
Sep 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
42,601
-9.11%
|
$2,470,858
$58.77 P/Share
|
|
Sep 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
42,601
+14.24%
|
$511,212
$12.23 P/Share
|
|
Sep 01
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
88,739
-12.43%
|
$5,146,862
$58.81 P/Share
|
|
Sep 01
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
98,739
+18.43%
|
$2,172,258
$22.08 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
41,420
-63.88%
|
$2,402,360
$58.25 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,917
+30.94%
|
$94,672
$16.06 P/Share
|
|
Aug 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
35,503
-45.34%
|
$355,030
$10.06 P/Share
|
|
Aug 17
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,828
-7.98%
|
$485,540
$55.65 P/Share
|
|
Aug 17
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,828
+7.39%
|
$88,280
$10.57 P/Share
|
|
Aug 01
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,614
+13.97%
|
-
|
|
Aug 01
2017
|
Michael Adam Bell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
16,822
-13.34%
|
$925,210
$55.85 P/Share
|
|
Aug 01
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,193
-3.96%
|
$230,615
$55.85 P/Share
|
|
Aug 01
2017
|
Thomas H. Lee Advisors, LLC |
BUY
Grant, award, or other acquisition
|
Direct |
8,712
+50.0%
|
-
|
|
Aug 01
2017
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,527
+14.05%
|
-
|
|
Aug 01
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+13.26%
|
-
|
|
Aug 01
2017
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct |
21,567
+12.93%
|
-
|
|
Jul 03
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,088
-1.46%
|
$63,104
$58.55 P/Share
|
|
Jul 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
956
-2.01%
|
$55,448
$58.55 P/Share
|